Results 41 to 50 of about 5,934 (217)

Lysergic acid diethylamide (LSD)

, 2019
Lysergic acid diethylamide (LSD) is a drug known for its hallucinogenic properties especially at high doses and in recent years has been used as a pharmacological model to study the neurological substrate of psychosis, the effect of antipsychotics, and ...
Kehayova, Gabriela; Department of Pharmacology, Toxicology and Pharmacotherapy, Faculty of Pharmacy, Medical University of Varna, Bulgaria, Marinov, Petko; Department of Pharmacology, Toxicology and Pharmacotherapy, Faculty of Pharmacy, Medical University of Varna, Bulgaria, Zlateva, Snezha; Department of Pharmacology, Toxicology and Pharmacotherapy, Faculty of Pharmacy, Medical University of Varna, Bulgaria   +2 more
core   +1 more source

Lysergic acid diethylamide (LSD-25): IX. Effect on snails

, 1955
"Certain species of snails are at least as sensitive to lysergic acid diethylamide (LSD-25) as are the Siamese fighting fish (Betta splendens). Ambularia cuprina (Mystery Snail) responds to LSD-25 with a typical, persistent, disorganized movement of the ...
Harold A. Abramson, Murray E. Jarvik, Abramson, Harold Alexander, Jarvik, Murray E.   +3 more
core   +1 more source

sj-docx-1-jop-10.1177_02698811221099650 – Supplemental material for Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)

, 2022
Supplemental material, sj-docx-1-jop-10.1177_02698811221099650 for Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD) by Emma I Kopra, Jason A Ferris, James J Rucker, Benjamin ...
Jason A Ferris (12385796), Benjamin McClure (12855027), Allan H Young (9559350), Emma I Kopra (12385793), Adam R Winstock (5196926), James J Rucker (9908841), Caroline S Copeland (12855030)   +6 more
core   +1 more source

Interference with testing for lysergic acid diethylamide [PDF]

Clinical Chemistry, 1997
Abstract We found a high rate (4.2%) of positive results for lysergic acid diethylamide (LSD) by Emit in 1898 urine samples that were submitted primarily from psychiatric patients for drugs-of-abuse (DOA) testing. Specimens that tested positive for LSD by Emit subsequently tested negative for LSD with two RIAs.
D, Ritter, C M, Cortese, L C, Edwards, J L, Barr, H D, Chung, C, Long   +5 more
openaire   +2 more sources

Lysergic Acid Diethylamide (LSD) and mystical experiences

, 2016
Lysergic acid diethylamide (LSD) is the best-known drug of a subtype of hallucinogens, commonly referred to as psychedelics. LSD is by far the most potent psychedelic and one of the most potent psychoactive substances ever discovered.
Lyvers, Michael, Michael Lyvers
core   +1 more source

sj-pptx-1-jop-10.1177_02698811221104641 – Supplemental material for Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice

, 2022
Supplemental material, sj-pptx-1-jop-10.1177_02698811221104641 for Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice by Lauri V Elsilä, Juliana Harkki, Emma Enberg ...
Anni-Maija Linden (206851), Alvar Martti (12876824), Juliana Harkki (12876818), Esa R Korpi (12876827), Lauri V Elsilä (12876815), Emma Enberg (12876821)   +5 more
core   +1 more source

Exploring new avenues: Psychedelic‐assisted therapy for young people

British Journal of Clinical Pharmacology, EarlyView.
Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic‐assisted therapy, using substances such as psilocybin and 3,4‐methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including ...
Ioanna Artemis Vamvakopoulou, Dasha Nicholls, David J. Nutt, Martina Di Simplicio   +3 more
wiley   +1 more source

Blockade of 5-Hydroxytryptamine Antidiuresis in Rats by 2-Bromlysergic Acid Diethylamide Tartrate and 1-Methyl-Lysergic Acid Butanolamide

, 1963
The effects of two lysergic acid derivatives, 2-bromlysergic acid diethylamide ‘BOL 148’ and 1-methyl-lysergic acid butanolamide ‘UML 491’ on the antidiuresis induced by 5-hydroxytryptamine ‘5-HT’ has been studied in rats given a dose of 1 mg./kg.
A Chodera
core   +1 more source

The Pharmacology of Lysergic Acid Diethylamide: A Review [PDF]

CNS Neuroscience & Therapeutics, 2008
Lysergic acid diethylamide (LSD) was synthesized in 1938 and its psychoactive effects discovered in 1943. It was used during the 1950s and 1960s as an experimental drug in psychiatric research for producing so‐called “experimental psychosis” by altering neurotransmitter system and in psychotherapeutic procedures (“psycholytic” and “psychedelic” therapy)
Torsten, Passie, John H, Halpern, Dirk O, Stichtenoth, Hinderk M, Emrich, Annelie, Hintzen   +4 more
openaire   +2 more sources

The Serotonin 2B (5‐HT2B) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression

Clinical Pharmacology &Therapeutics, EarlyView.
Major depressive disorder (MDD) and treatment‐resistant depression (TRD) remain leading causes of disability, providing the impetus for receptor‐level treatment strategies beyond monoamine reuptake. The serotonin 5‐HT2B receptor (5‐HT2BR) is uniquely positioned at the interface of central‐antidepressant mechanisms and peripheral cardiac risks.
Gia Han Le, Sabrina Wong, Danica E. Johnson, Diana K. Orsini, Yang Jing Zheng, Kayla M. Teopiz, Christine E. Dri, Joshua D. Rosenblat, Roger S. McIntyre   +8 more
wiley   +1 more source